Newsroom

David E. Williams November 11, 2021 Hong Tang grew up in rural China, and was encouraged by her pharmacist sister to become a physician....

Moira Gunn November 9 On this week’s Tech Nation, Moira speaks with Dr. Sidarta Ribeiro, Deputy Director of the Brain Institute at the...

To help celebrate GEN’s 40th Anniversary with this special October issue, we asked scientists and business professionals in academia and...

In contrast to the innovations in cancer treatments that help drive improved survival, there are far fewer innovations targeting...

- Top-line readout of clinical study results anticipated by the end of 2021 SEATTLE, Sept. 7, 2021 /PRNewswire/ -- OnQuality...

Link to Episode: http://thebioreport.com/2021/07/22/targeting-cancer-drug-side-effects-at-their-source/ While great strides have been...

Episode link: https://www.reorientpodcast.com/episodes/hong-tang Dr. Hong Tang is the Chief Medical Officer and co-founder of OnQuality...

Mike discusses the advancements that OnQuality Pharmaceuticals is making toward to the treatment of toxicities caused by cancer...

By Wayne Koberstein This article draws on the experience of five company CEOs with various backgrounds and views of stealth transitions....

Dr. Michael McCullar, CEO, and Dr. Hong Tang, Chief Medical Officer at OnQuality Pharmaceuticals, a clinical stage pharma company...